RadNet Q1 revenue rises 22% on advanced imaging volumes

RadNet, Inc.

RadNet, Inc.

RDNT

0.00


Overview

  • US diagnostic imaging provider's Q1 revenue rose 22% yr/yr, driven by advanced imaging growth

  • Adjusted diluted loss per share for Q1 missed analyst expectations, but narrowed from prior year

  • Company raised full-year 2026 Imaging Center revenue, adjusted EBITDA and free cash flow guidance


Outlook

  • RadNet raises 2026 Imaging Center revenue guidance to $2.355-$2.405 bln from $2.325-$2.375 bln

  • Company lifts 2026 Imaging Center adj EBITDA forecast to $340-$353 mln from $335-$348 mln

  • RadNet reaffirms 2026 Digital Health segment guidance ranges


Result Drivers

  • ADVANCED IMAGING GROWTH - Co said 19.7% increase in aggregate advanced imaging volumes, including MRI, CT and PET/CT, drove revenue gains

  • DIGITAL HEALTH EXPANSION - Digital Health segment revenue rose 51.5%, with annual recurring revenue nearly doubling, though profitability was impacted by infrastructure investments

  • WEATHER IMPACT AND RECOVERY - Severe winter weather reduced revenue and adjusted EBITDA early in Q1, but business rebounded in March


Company press release: ID:nGNXBlwrl


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

$30.41 mln

Q1 Adjusted EPS

Miss

-$0.28

-$0.19 (6 Analysts)

Q1 EPS

-$0.43

Q1 Net Income

-$24.73 mln

Q1 Income from operations

-$23.90 mln

Q1 Operating Expenses

$599.53 mln

Q1 Pretax Profit

-$32.83 mln

Q1 Total Service Revenue

$575.63 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for RadNet Inc is $91.50, about 57.2% above its May 8 closing price of $58.19

  • The stock recently traded at 77 times the next 12-month earnings vs. a P/E of 90 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.